Athletes and suspected catecholaminergic polymorphic ventricular tachycardia: Awareness and current knowledge

J Cardiovasc Electrophysiol. 2023 Oct;34(10):2095-2101. doi: 10.1111/jce.16045. Epub 2023 Sep 1.


Introduction: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a cardiac inherited arrhythmogenic disease potentially leading to sudden cardiac death that is determined by electrical instability exacerbated by acute adrenergic tone.

Methods and results: Despite its life-threatening nature, CPVT remains potentially unnoticed since diagnosis may be difficult especially in apparently healthy athletes. This review summarizes current knowledge and shortcomings of CPVT, focusing on genetics, arrhythmic mechanisms, sport preparticipation screening, and current recommendations.

Conclusions: The paper captures the importance of CPVT athletes regarding the necessity of risk stratification, as well as the importance of maintaining a healthy lifestyle.

Keywords: Brugada syndrome; cardiac arrest; sudden death; ventricular tachycardia.

Publication types

  • Review